Department of Defense Ovarian Cancer Program: Clinical Development Award 2016

The goal of this award mechanism is to accelerate the clinical introduction of medical products and technologies that target ovarian cancer biology. Near-term clinical impact is expected.

Proof-of-concept demonstrating the potential utility of the proposed product or a prototype/preliminary version of the proposed product should already be established; thus, preclinical studies in animals are not allowed.

Small-scale clinical trials (Phase 0, Phase 1, Pilot), studies enriching a clinical trial, and projects related to or associated with ongoing or completed clinical trials are allowed.

Relevant data, either published or unpublished, that support the study rationale are required.

Funding & Duration

The anticipated direct costs budgeted for the entire period of performance will not exceed US $600,000 (approx AUD $791,000).

The maximum period of performance is 3 years.


Independent investigator at or above the level of Assistant Professor (or equivalent) are eligible to submit applications.

Non-domestic (non-U.S.) Entities (Foreign Institutions) are eligible to apply.

Related  Schemes

Submission Requirements & Due Dates

Further Information

This entry was posted in Engineering, Computer & Mathematical Sciences, Funding by Award Type, Grants (Project Funds), Health & Medical Sciences, International Funding and tagged . Bookmark the permalink.

Comments are closed.